Jia Y. Wang
127 Dongming Road
Zhengzhou, 450008, China
Zhengzhou, 450008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Tumor flare-like response: A novel imaging phenomenon with predictive significance in triple negative breast cancer patients undergoing neoadjuvant immuno-chemotherapy.
Journal: Breast (Edinburgh, Scotland)
Published: July 29, 2025
Global patterns and risk factors of breast cancer in women under 35: a population-based study.
Journal: Breast (Edinburgh, Scotland)
Published: June 21, 2025
Impact of Hormone Receptor Status and HER2 Expression on Neoadjuvant Targeted Therapy Response in HER2-Positive Breast Cancer: A Multicenter Retrospective Study.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: January 16, 2025
Applying a multi-task and multi-instance framework to predict axillary lymph node metastases in breast cancer.
Journal: NPJ precision oncology
Published: November 08, 2024
Next-generation sequencing based deep learning model for prediction of HER2 status and response to HER2-targeted neoadjuvant chemotherapy.
Journal: Journal of cancer research and clinical oncology
Published: October 14, 2024
Circumferential periareolar incision length as a risk factor for skin necrosis after nipple-sparing mastectomy with deep inferior epigastric perforator flap reconstruction.
Journal: BMC cancer
Published: July 26, 2024
Identification potential biomarkers for diagnosis, and progress of breast cancer by using high-pressure photon ionization time-of-flight mass spectrometry.
Journal: Analytica chimica acta
Published: March 22, 2024
The use of longitudinal CT-based radiomics and clinicopathological features predicts the pathological complete response of metastasized axillary lymph nodes in breast cancer.
Journal: BMC cancer
Published: November 27, 2023
Axillary lymph node dissection in triple-negative or HER2-positive breast cancer patients with clinical N2 achieving pathological complete response after neoadjuvant therapy: Is it necessary?
Journal: Breast (Edinburgh, Scotland)
Published: November 09, 2023
Comparison of the Response to Neoadjuvant Therapy Between Immunohistochemistry HER2 (3+) and HER2 (2+)/ISH+ Early-Stage Breast Cancer: A Retrospective Multicenter Cohort Study.
Journal: The oncologist
Published: October 28, 2023
DAXX drives de novo lipogenesis and contributes to tumorigenesis.
Journal: Nature communications
Published: February 03, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026